2013-04-25 (this is for AWARE 1..we are waiting for AWARE II)
Maxim Biomedical and Calypte Biomedical announce new distribution agreement for purchase of both Maxim's HIV-1 Limiting Antigen (LAg)-Avidity EIA Kit and Calypte's Aware BED EIA HIV-1 Incidence Test. For more information see official flyer and press release.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.